Hamady Robert Ramsey sold $158K of SMR

Hamady Robert Ramsey (Chief Financial Officer) sold 20,000 shares of NUSCALE POWER Corp (SMR) at $7.89 ($0.16M total) on 2026-10-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hamady Robert Ramsey
Published Oct 5, 2026, 8:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 8:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$SMR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The sale represents a routine insider divestment with modest size, unlikely to move the stock significantly.

02

Market read

A small insider sale filed via Form 4; low immediate trading relevance.

03

What to watch

The CFO's 10b5‑1 plan indicates pre‑planned sales, reducing the likelihood of a negative informational signal.

Relevance 3/10Novelty 3/10Timing: post‑market filing

Background

Form 4 filings disclose insider transactions and are primary sources for such events.

Market effects

Minimal effect on the broader clean‑energy sector; the sale is company‑specific.

No discernible regional impact.

Limited to investors tracking insider activity.

Counterpoint

Some traders may view the sale as a signal of insider concern and short the stock.

Key entities

  • Nuscale Power Corp.

    US‑listed clean‑energy firm (ticker NUS).

  • Hamady Robert Ramsey

    Chief Financial Officer of Nuscale Power.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

High

Why is Nuscale Power stock down 6% today?

Nuscale Power's stock dropped 6.5% in pre-market trading after Barclays downgraded it to Underweight and cut its price target to $5 from $11. The company faces multiple analyst downgrades, legal investigations, and dilution concerns. Its stock is near a 52-week low of $5.44, with weak customer commitments and expected negative free cash flow contributing to the decline.

$SMRLowAI 8/10

NuScale Power Falls 7% as 10-Year Treasury Yield Climbs to 5.26%; Energy Fuels Drops 9%, Oklo Slides 5%

NuScale Power (SMR) fell 7% to $6.04, Energy Fuels (UUUU) dropped 9% to $8.43, and Oklo (OKLO) slid 5% to $30.11 as 10-year Treasury yields rose to 5.26%. The Global X Uranium ETF (URA) declined 4%, outpacing the broader market's 0.8% drop. Rising yields impact long-duration assets like nuclear developers, affecting both valuation and project financing costs.

$GOOGHighAI 8/10

Google Signed a Deal for Existing Reactors. So Why Did Oklo and NuScale Jump on the Constellation Energy News? The Read-Through Investors Are Missing.

Alphabet (GOOG, GOOGL) agreed to a 15-year and 20-year deal with Constellation Energy (CEG) for nuclear power, investing $4.3B in new capacity. Oklo (OKLO) and NuScale (SMR) shares also rose, despite no direct involvement. The companies develop small modular reactors (SMRs) for specific facilities, differing from Constellation's large-scale plants. Investors see broader nuclear energy growth, with SMRs expected to play a significant role by 2050, according to industry estimates.

$SMRMed

SMR Stock Slides As UBS Downgrade Triggers Legal Scrutiny

NuScale Power Corporation (NYSE: SMR) shares fell 3.13% on October 13, 2026, closing at $6.49. The decline follows a UBS downgrade from Neutral to Sell, with a price target cut from $10 to $6, citing concerns over delayed deployments, weak customer commitments, and cash burn. Additionally, Pomerantz LLP announced an investigation into potential securities fraud, adding to the uncertainty.

$SMRHigh

SMR Stock Slides As Fraud Probe Follows UBS Downgrade

NuScale Power Corporation (NYSE: SMR) shares fell 7.29% on October 12, 2026, amid concerns over project delays, a UBS downgrade, and a fraud probe. UBS cut its price target to $6, citing execution risks and negative free cash flow expectations. SMR reported Q2 2026 revenue of $75,000 and a net loss of $47.54M. Analysts' average price target is $12.37, with a consensus 'Hold' rating.